Zonisamide in the management of epilepsy in the elderly

Zonisamide (ZNS), a second-generation antiepileptic drug, indicated as add-on treatment of focal epilepsy, has been recently approved as monotherapy for the treatment of partial seizures in adults affected by newly diagnosed epilepsy in Europe. Evidence on the efficacy and tolerability of antiepilep...

Descripción completa

Detalles Bibliográficos
Autores principales: Romigi, Andrea, Femia, Eti A, Fattore, Cinzia, Vitrani, Giuseppe, Di Gennaro, Giancarlo, Franco, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467644/
https://www.ncbi.nlm.nih.gov/pubmed/26089654
http://dx.doi.org/10.2147/CIA.S50819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467644/
https://www.ncbi.nlm.nih.gov/pubmed/26089654
http://dx.doi.org/10.2147/CIA.S50819

Ejemplares similares